LIXTW लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:27):
Our systems believe the stock currently is overvalued by -0.66% compare to its pairs and should correct downwards.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases...

Stats
आज की मात्रा	585
औसत मात्रा	7 396
बाजार मूल्य	150 470
EPS	$-0.430 ( Q1 \| 2024-05-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI -2.94%

ABCL 1.65%

ABCM 0.04%

ABEO -2.38%

ABIO -1.68%

ABOS 1.40%

ABSI 2.38%

ABUS -2.30%

ABVX -3.53%

ACAD -0.64%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL -3.00%

ACHV -1.61%

ACIU -1.00%

ACLX -0.09%

ACRV -4.79%

ACST -1.63%

ACXP 0.28%

ADAG 4.64%

ADAP -2.91%

ADGI 0.87%

ADIL 0.54%

ADMA -2.68%

ADPT -0.30%

ADTX -3.47%

ADVM -3.91%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.82%

AGIO -2.13%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.12%

AKRO -2.81%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -2.29%

ALGS -2.41%

ALKS -0.25%

ALLK -8.55%

ALLO -6.23%

ALLR -3.22%

ALNA 3.16%

ALNY 1.85%

ALPN 0.02%

ALPX 0.00%

ALRN -0.33%

ALT -9.65%

ALVR -0.56%

ALXN 0.00%

ALXO -10.96%

ALZN 4.78%

AMRN -0.31%

AMTI -3.13%

ANAB 0.46%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.66%

ANPC -3.15%

APGE -0.91%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.09%

APLT -4.29%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 3.27%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.90%

ARDS -14.23%

ARDX -0.66%

ARGX -0.82%

ARNA 0.00%

ARPO -0.90%

ARQT -0.73%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.76%

ARWR -1.56%

ASLN -5.04%

ASMB -7.14%

ASND -0.94%

ATAI -1.48%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 3.41%

ATRA -3.45%

ATXI 1.93%

ATXS -0.44%

AUPH -1.17%

AURA 1.17%

AUTL -2.01%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -5.48%

AVTX -1.25%

AVXL -2.96%

AXLA 0.00%

AXSM -1.99%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.98%

BCAB 1.96%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 7.14%

BCRX 1.32%

BCTX 7.65%

BCTXW -16.29%

BCYC 1.33%

BDRX -4.10%

BDTX -0.43%

BEAM 0.43%

BFRA -2.91%

BGNE -2.72%

BIOR -3.79%

BIVI 2.39%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.52%

BMEA -9.97%

BMRN 0.41%

BNOX -2.22%

BNTC -2.11%

BNTX -1.46%

BOLD -8.11%

BOLT 1.31%

BPMC -1.21%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 22.46%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.48%

CADL -1.42%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.21%

CARM 13.08%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.16%

CCCC -5.31%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.84%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.00%

CDXS 6.07%

CELC -4.25%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.89%

CERO -4.50%

CEROW -10.18%

CFRX -27.95%

CGEM -2.25%

CGEN -3.85%

CGON -0.54%

CGTX -5.11%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 2.56%

CINGW 34.95%

CKPT -2.87%

CLBS -16.75%

CLDX -2.47%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.04%

CLSD 1.02%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -7.50%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -39.16%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.00%

CORT 2.34%

COYA -1.46%

CPRX -0.99%

CRBP -1.98%

CRBU -4.83%

CRDF -2.20%

CRGX 1.28%

CRIS -0.38%

CRNX -5.90%

CRSP 0.93%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.29%

CTNM -1.35%

CTXR 2.03%

CUE 3.53%

CVAC -2.54%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 9.38%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.89%

CYTO -2.73%

DARE 6.41%

DAWN 0.52%

DBTX -0.81%

DBVT 4.44%

DFFN 10.28%

DICE 0.06%

DMAC 34.01%

DNLI -1.43%

DNTH -6.35%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.21%

DTIL 0.31%

DYAI 9.68%

EARS -1.77%

EDIT -2.52%

EDSA -1.00%

EFTR 8.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -5.37%

ELOX 7.69%

ELTX -0.88%

ELVN -4.05%

ELYM 1.67%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.13%

ENTA -0.49%

ENTO -4.42%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -1.02%

ETON 1.68%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX 0.00%

EXAI -0.58%

EXEL -0.36%

EYEG -0.69%

EYEN 1.48%

EYPT -0.24%

FATE -7.66%

FBIO 0.59%

FBIOP 0.92%

FBLG -14.30%

FBRX -0.04%

FDMT -4.86%

FENC -0.97%

FGEN -5.13%

FHTX 2.10%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.58%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.31%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -1.49%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.31%

GHRS -1.59%

GLMD -2.32%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -2.36%

GLYC -10.72%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.92%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -9.52%

GOVX 7.48%

GOVXW -49.04%

GPCR -6.51%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.08%

GRTX 0.00%

GTHX 0.45%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -1.22%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.57%

HOOK 0.80%

HOTH -2.70%

HOWL -2.35%

HRMY 0.85%

HRTX 2.79%

HSTO 0.00%

HUMA 0.81%

HUMAW -0.01%

IBRX -3.90%

ICCC 0.22%

ICPT 0.21%

ICU 16.49%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -2.07%

IFRX -1.85%

IGMS -0.15%

IKNA 0.30%

IKT 1.42%

IMAB -0.58%

IMCR -2.62%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.60%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -1.50%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.63%

INAB 0.00%

INBX 0.53%

INCY -0.82%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -0.38%

INMB 3.01%

INO -2.21%

INSM -0.90%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.42%

IONS 0.40%

IOVA -2.37%

IPA 2.46%

IPHA 5.58%

IPSC -2.15%

IRON -2.54%

ISEE 0.38%

ITOS -1.50%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.05%

JANX -4.07%

JAZZ -0.66%

JNCE 0.00%

JSPR -5.93%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.95%

KDNY 0.22%

KMPH -0.34%

KNSA -2.80%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.83%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -6.34%

KRTX 0.03%

KRYS -0.90%

KTRA 17.67%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.41%

KYTX -4.64%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.71%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.02%

LENZ -3.36%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.61%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.61%

LPCN -4.05%

LPTX -1.10%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 1.76%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -1.76%

LYEL -34.44%

LYRA 2.33%

MACK 0.10%

MBIO -9.32%

MBRX -1.72%

MCRB 1.23%

MDGL -2.70%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -3.77%

MGX -2.68%

MIRM -1.80%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.73%

MNKD -1.00%

MNMD 0.14%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.29%

MORF -3.86%

MREO -4.72%

MRKR 2.68%

MRNA -4.87%

MRNS -4.04%

MRSN -2.86%

MRTX -0.17%

MRUS 0.04%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.24%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.15%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.90%

NEXI 2.60%

NGM -1.28%

NGNE -2.03%

NKGN 6.78%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.82%

NLSPW 26.67%

NMRA -1.48%

NMTR -42.97%

NOVN -24.84%

NRBO 12.08%

NRIX -0.53%

NRSN -7.05%

NRSNW 0.00%

NRXP -4.09%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.16%

NTRBW -31.07%

NUVL -2.00%

NVAX -2.36%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.13%

OABIW -10.06%

OBIO -2.48%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -2.21%

OCUP 1.96%

ODT -4.27%

OKYO 1.51%

OLMA -5.45%

OMER -1.28%

OMGA 5.00%

ONCO 5.04%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -2.07%

ORIC -3.56%

ORMP 15.18%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.44%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -6.75%

PBYI 1.69%

PCSA 0.00%

PCVX -0.37%

PDSB -2.69%

PEPG 0.27%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.10%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.68%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.00%

PRQR -0.01%

PRTA -2.65%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -6.04%

PSTX -1.16%

PTCT -0.28%

PTE -0.82%

PTGX -1.76%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.96%

QLGN -4.49%

QNCX 5.70%

QNRX 0.37%

QSI -11.23%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.92%

RARE 1.41%

RCKT -7.75%

REGN -0.70%

RENB -3.42%

REPL -2.50%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.36%

RIGL -3.28%

RLAY -4.75%

RLMD 0.33%

RLYB 0.00%

RNA -0.56%

RNAC -4.80%

RNAZ -0.96%

RNXT 1.88%

ROIV -1.95%

ROIVW 4.56%

RPHM 0.00%

RPRX -0.06%

RPTX -2.64%

RUBY 2.70%

RVLP -32.05%

RVMD -1.29%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.58%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.20%

RYTM -6.51%

RYZB 0.02%

RZLT 2.08%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -3.87%

SAVA -0.31%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 0.00%

SCPS 0.00%

SEEL -4.48%

SEER -0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.23%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -7.24%

SLGL 4.00%

SLN -4.21%

SLNO -4.03%

SLRX 6.04%

SLS -2.58%

SMMT -2.99%

SNDX 0.77%

SNGX -4.17%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.32%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.14%

SRRA 0.00%

SRRK -2.85%

SRZN -2.45%

STAB 0.00%

STOK -5.29%

STRO -2.76%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.29%

SWTX 0.34%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -7.62%

TARS -0.58%

TBPH 0.60%

TCBP 2.73%

TCDA 0.00%

TCON -1.35%

TCRR 0.00%

TCRT 1.59%

TCRX 2.83%

TECH -0.14%

TENX -1.27%

TERN -7.86%

TFFP -3.05%

TGTX -2.97%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -3.09%

TNGX -2.89%

TNXP -6.39%

TNYA -7.01%

TPST 2.87%

TRDA -3.93%

TRVI 1.15%

TRVN 2.92%

TSHA -24.54%

TSVT -2.79%

TTNP -9.27%

TVTX 0.63%

TYRA -6.95%

UBX -2.12%

UNCY -2.43%

URGN -0.73%

UTHR -0.39%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL 0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.78%

VERU 0.79%

VERV -2.96%

VIGL 5.11%

VINC 1.62%

VIR 0.54%

VIRI -1.57%

VIRX 2.40%

VKTX -1.67%

VLON -13.04%

VNDA -2.28%

VOR -2.02%

VRCA -0.07%

VRDN -4.31%

VRNA -1.33%

VRPX 0.38%

VRTX 0.39%

VSTM -3.58%

VTGN -0.45%

VTVT -2.97%

VTYX 0.00%

VXRT -2.88%

VYGR -1.53%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.51%

XBIO 0.93%

XBIT 1.77%

XCUR 3.58%

XENE -2.85%

XERS 2.38%

XFOR 2.09%

XLO 2.00%

XLRN 0.00%

XNCR 0.47%

XOMA -3.57%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.29%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-09-26	Van Der Baan Bastiaan Jeroen	Buy	250 000	Options to Purchase Common Stock
2023-10-03	Bernards Rene	Buy	5 527	Common Stock
2023-10-02	Bernards Rene	Buy	4 473	Common Stock
2023-10-03	Van Der Baan Bastiaan Jeroen	Buy	10 000	Common Stock
2023-10-02	Bernards Rene	Buy	4 473	Common Stock

INSIDER POWER
100.00
Last 33 transactions
Buy: 1 558 612 \| Sell: 83 334

सहसंबंध (AI algo v.1.1b): Overvalued: -0.66% $0.0673 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

Lixte Biotechnology सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Lixte Biotechnology वित्तीय

Annual	2023
राजस्व:	$0
सकल लाभ:	$0 (0.00 %)
EPS:	$-2.66

FY	2023
राजस्व:	$0
सकल लाभ:	$0 (0.00 %)
EPS:	$-2.66

FY	2022
राजस्व:	$0
सकल लाभ:	$0 (0.00 %)
EPS:	$-39.85

FY	2021
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Lixte Biotechnology Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Lixte Biotechnology

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher\'s disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.